Physician profile
Sonya Mitchell Miles
NPI 1750581781
$6,205.48
in general payments reported to CMS, 2019-2025
32 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $930 · 2020: $552 · 2021: $838 · 2022: $745 · 2023: $960 · 2024: $1,079 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,043 · Entertainment: $58.16 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,042.65 |
| Entertainment | $58.16 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $1,257.80 | 2021-2025 | Acthar |
| Alcon Vision LLC | $1,160.42 | 2019-2025 | Clareon, Ngenuity, Clareon Panoptix Pro |
| Abbvie INC. | $434.81 | 2022-2025 | |
| Allergan, INC. | $349.92 | 2019-2022 | |
| Rxsight INC | $305.11 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Eyepoint US, INC. | $242.71 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $230.31 | 2019-2021 | |
| Ocular Therapeutix, INC. | $225.93 | 2023-2025 | Dextenza |
| Harrow Eye, LLC | $219.74 | 2023-2025 | Iheezo, Triesence |
| Glaukos Corporation | $186.00 | 2022-2025 | Photrexa Viscous and Photrexa, Idosetr, Idose |
| Aerie Pharmaceuticals, INC. | $182.29 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $173.46 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Novartis Pharmaceuticals Corporation | $169.69 | 2019-2023 | |
| Oyster Point Pharma, INC. | $133.41 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Surgical Vision, INC. | $119.60 | 2019-2025 | Tecnis Iol |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $99.04 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Regeneron Pharmaceuticals, INC. | $98.22 | 2024 | Eylea Hd |
| Sun Pharmaceutical Industries INC. | $79.67 | 2019-2023 | Cequa |
| Eyevance Pharmaceuticals LLC | $71.06 | 2021 | |
| Ani Pharmaceuticals, INC. | $64.77 | 2024-2025 | Purified Cortrophin Gel, Iluvien |
| Nova Eye, INC. | $58.16 | 2025 | |
| Apellis Pharmaceuticals, INC. | $56.10 | 2024 | Syfovre |
| Ivantis, INC | $51.68 | 2020-2021 | |
| Biotissue Holdings INC. | $39.47 | 2020-2024 | |
| Johnson & Johnson Vision Care, INC. | $34.24 | 2019-2020 | |
| Iridex Corporation | $29.83 | 2019-2020 | |
| Rayner Intraocular Lenses Limited | $29.10 | 2024 | Omidria |
| Dompe US, INC. | $25.16 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.10 | 2025 | Caplyta |
| Shire North American Group INC | $19.57 | 2019 | |
| Beaver-Visitec International, INC. | $19.42 | 2021 | |
| New World Medical,INC. | $13.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.